文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

PET/CT与增强CT对非小细胞肺癌局部区域淋巴结的诊断价值比较

Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer.

作者信息

Yang Wenfeng, Fu Zheng, Yu Jinming, Yuan Shuanghu, Zhang Baijiang, Li Daotang, Xing Ligang, Zhao Dongbo, Mu Dianbin, Sun Xiaorong, Fang Yufang, Huang Yong, Li Wanhu

机构信息

Department of Thoracic Surgery, Shandong Cancer Hospital and Institute, Jinan 250117, Shandong Province, China.

出版信息

Lung Cancer. 2008 Jul;61(1):35-43. doi: 10.1016/j.lungcan.2007.11.007. Epub 2008 Jan 4.


DOI:10.1016/j.lungcan.2007.11.007
PMID:18177978
Abstract

PURPOSE: To compare the diagnostic efficacies of integrated (18)F FDG PET/CT images and contrast-enhanced helical CT images in locoregional lymph node metastasis in the patients with non-small cell lung cancer (NSCLC). METHODS: From June 2005 to June 2007, 122 potentially operable patients with proven or suspected non-small cell lung cancer underwent integrated PET/CT and contrast-enhanced CT scans followed by surgical nodal staging. The results of reviewing PET/CT and enhanced CT images for the locoregional lymph node metastasis were compared in relation to pathologic findings. RESULTS: Preoperative nodal staging was compared with postoperative histopathological staging, 80% (98 of 122) of patients correctly staged, 13% (16 of 122) of patients were overstaged, and 7% (8 of 122) were understaged by PET/CT, while those values for CT were 56% (68 of 122), 26% (32 of 122), and 18% (22 of 122), respectively. The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of PET/CT for lymph nodes were 86%, 85%, 85%, 64%, 95%, respectively; compared with 69%, 71%, 70%, 43%, 88% for CT (P=0.000, 0.000, 0.000, 0.001, 0.001, respectively). 81% false-negative interpretations and 72% false-positive interpretations on CT were corrected by PET/CT. 57% false-negative interpretations and 45% false-positive interpretations on PET/CT were corrected by CT. 6 % (9 of 153) positive lymph nodes and 8% (40 of 486) negative nodes at pathology were incorrectly diagnosed both by PET/CT and CT. CONCLUSION: Integrated PET/CT improves the sensitivity, specificity, accuracy, positive predictive value, and negative predictive value than enhanced CT in the assessment of locoregional lymph nodes, and provides more efficient and accurate data of nodal staging, with a better effect on diagnosis and therapy in non-small cell lung cancer.

摘要

目的:比较18F FDG PET/CT融合图像与对比增强螺旋CT图像对非小细胞肺癌(NSCLC)患者局部区域淋巴结转移的诊断效能。 方法:2005年6月至2007年6月,122例经证实或怀疑为非小细胞肺癌且可能适合手术的患者接受了PET/CT融合扫描及对比增强CT扫描,随后进行手术淋巴结分期。将PET/CT和增强CT图像对局部区域淋巴结转移的检查结果与病理结果进行比较。 结果:将术前淋巴结分期与术后组织病理学分期进行比较,PET/CT对80%(122例中的98例)患者分期正确,13%(122例中的16例)患者分期过高,7%(122例中的8例)患者分期过低;而CT的相应比例分别为56%(122例中的68例)、26%(122例中的32例)和18%(122例中的22例)。PET/CT对淋巴结的敏感性、特异性、准确性、阳性预测值和阴性预测值分别为86%、85%、85%、64%、95%;而CT的相应值分别为69%、71%、70%、43%、88%(P值分别为0.000、0.000、0.000、0.001、0.001)。PET/CT纠正了CT上81%的假阴性判读和72%的假阳性判读。CT纠正了PET/CT上57%的假阴性判读和45%的假阳性判读。病理检查为阳性的淋巴结中有6%(153个中的9个)以及病理检查为阴性的淋巴结中有8%(486个中的40个)被PET/CT和CT均误诊。 结论:在评估局部区域淋巴结方面,PET/CT融合成像比增强CT提高了敏感性、特异性、准确性、阳性预测值和阴性预测值,能提供更有效、准确的淋巴结分期数据,对非小细胞肺癌的诊断和治疗有更好的效果。

相似文献

[1]
Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer.

Lung Cancer. 2008-7

[2]
Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.

Eur J Cardiothorac Surg. 2009-5-22

[3]
The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancer.

Ann Thorac Surg. 2004-9

[4]
Accuracy of 18F-FDG PET/CT for lymph node staging in non-small-cell lung cancers.

Chin Med J (Engl). 2009-8-5

[5]
FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.

Ann Thorac Cardiovasc Surg. 2006-4

[6]
[Evaluation of the diagnostic value of (18)F-FDG PET-CT and enhanced CT for staging of lymph node metastasis in non-small cell lung cancer].

Zhonghua Zhong Liu Za Zhi. 2009-12

[7]
Characteristics of advantages of positron emission tomography over computed tomography for N-staging in lung cancer patients.

Jpn J Clin Oncol. 2006-11

[8]
18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.

J Nucl Med. 2006-5

[9]
Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

N Engl J Med. 2003-6-19

[10]
Integrated positron emission tomography and computed tomography in preoperative lymph node staging of non-small cell lung cancer.

Chin Med J (Engl). 2014

引用本文的文献

[1]
Consistency and prognostic value of preoperative staging and postoperative pathological staging using F-FDG PET/MRI in patients with non-small cell lung cancer.

Ann Nucl Med. 2022-12

[2]
Mediastinal lymph node staging for lung cancer.

Mediastinum. 2019-8-19

[3]
A nomogram for predicting the risk of lymph node metastasis in T1-2 non-small-cell lung cancer based on PET/CT and clinical characteristics.

Transl Lung Cancer Res. 2021-1

[4]
Comparing the diagnostic value of F-FDG-PET/CT versus CT for differentiating benign and malignant solitary pulmonary nodules: a meta-analysis.

J Thorac Dis. 2019-5

[5]
Comparison of 18F-FDG PET/CT and DWI for detection of mediastinal nodal metastasis in non-small cell lung cancer: A meta-analysis.

PLoS One. 2017-3-2

[6]
Comparison of Positron Emission Tomography Using 2-[18F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[18F]-fluorothymidine in Lung Cancer Imaging.

Chin Med J (Engl). 2016-12-20

[7]
A pilot study imaging integrin αvβ3 with RGD PET/CT in suspected lung cancer patients.

Eur J Nucl Med Mol Imaging. 2015-12

[8]
Usefulness of the neutrophil-to-lymphocyte ratio in predicting lymph node metastasis in patients with non-small cell lung cancer.

Tumour Biol. 2015-9

[9]
(18)F-fluorodeoxyglucose positron emission tomography/computed tomography accuracy in the staging of non-small cell lung cancer: review and cost-effectiveness.

Radiol Res Pract. 2014

[10]
PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer.

Cochrane Database Syst Rev. 2014-11-13

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索